SAN DIEGO, Dec. 05, 2017 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NYSE:EFX shares against Equifax Inc. in connection with the massive data breach.
Investors, who purchased shares of Equifax Inc. (NYSE:EFX) in 2016 or earlier and continue to hold any of those NYSE:EFX shares, should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
On September 7, 2017, Equifax Inc. announced that criminals had exploited a website application vulnerability to gain access to the private information of approximately 143 million U.S. consumers between mid-May and July 2017.
On September 11, 2017, a lawsuit was filed against Equifax Inc. over alleged violations of Securities. The plaintiff alleges that the Defendants issued materially false and/or misleading statements and/or failed to disclose that Equifax Inc. failed to maintain adequate measures to protect its data systems, that Equifax Inc. failed to maintain adequate monitoring systems to detect security breaches, that Equifax Inc. failed to maintain proper security systems, controls and monitoring systems in place, and that as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.
Those who purchased Equifax Inc. (NYSE:EFX) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



